Home›Stock Screener›Venus Remedies›Quarterly Results

Venus Remedies Quarterly Results

Latest Quarter Net Profit
₹26 Cr
QSept 2026
Quarterly Results

Venus Remedies quarterly results. In Sept 2026, Venus Remedies (VENUSREM) reported revenue ₹219 Cr and net profit ₹26 Cr — revenue +12.3% YoY. For annual financials, live price and key ratios, visit Venus Remedies screener.

VENUSREM Quarterly Results — Revenue, Profit & EPS Highlights

Venus Remedies latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. View VENUSREM 52-week chart for the annual high/low range and current price position.

  • Revenue of ₹219 Cr in Sept 2026 (-17.0% vs Mar 2026, +12.3% vs Sept 2025)
  • Net Profit of ₹26 Cr in Sept 2026 (-45.8% vs Mar 2026, +30.0% vs Sept 2025)
  • EBITDA of ₹43 Cr in Sept 2026 (-36.8% vs Mar 2026)
  • Operating Margin of 19.0% in Sept 2026 (-5.0pp vs Mar 2026)
  • Earnings Per Share of ₹19.19 in Sept 2026 (-46.0% vs Mar 2026)

Venus Remedies Quarterly Results — Revenue, EBITDA, Net Profit & EPS

VENUSREM quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 QoQ YoY
Revenue (₹ Cr) 219 264 182 195 202 -17.0% 12.3%
Net Profit (₹ Cr) 26 48 23 20 21 - -
EBITDA (₹ Cr) 43 68 37 33 36 - -
EPS (₹) 19.19 35.53 17.18 15.06 15.71 - -
Operating Margin (%) 19.0% 24.0% 19.0% 16.0% 15.0% - -

VENUSREM Share Price Trend — 1-Year Movement Across Quarterly Results

Venus Remedies 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Also explore VENUSREM share price data to track price trends across different timeframes.

Profitability Ratios

Profit Margin 11.9%
EBITDA Margin 19.6%
Operating Margin 19.0%
ROE (Annual) 15.7%

Balance Sheet Highlights

Total Assets ₹854 Cr
Total Equity ₹664 Cr
Current Assets ₹ Cr
Current Liabilities ₹28 Cr

Cash Flow Analysis

Operating Cash Flow ₹156 Cr
Investing Cash Flow ₹-185 Cr
Financing Cash Flow ₹-3 Cr
Net Cash Flow ₹-32 Cr

Current Market Data

Current Price ₹1501.60
Exchange NSE
Last Updated Nov 19, 2026

VENUSREM vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Venus Remedies latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1900.0 16,617 1,995 +10.6% - 12.0% 228.9
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11178.0 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4611.0 4,111 364 +27.7% +42.2% 8.9% 400.6
Apollo Hospitals
Sept 2026
₹126,832.45 Cr 8738.0 7,673 660 +15.2% - 8.6% 199.4
Laurus Labs
Sept 2026
₹125,946.78 Cr 2306.0 2,219 436 +21.7% - 19.6% 282.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores